Bruker MALDI Biotypher system maintenance agreement

The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services is seeking preventative and remedial maintenance services for a Bruker MALDI Biotyper system located within the Division of Core Laboratory Services and Responses (DCLSR). This maintenance agreement is intended to ensure compliance with the organization's Quality Management System (QMS) requirements. The CDC intends to award this contract to Bruker Scientific LLC as a sole source procurement under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested vendors may submit expressions of interest or proposals to demonstrate their capability to respond to the requirement. All responses must be submitted via email to the Contracting Officer at uex0@cdc.gov by 5:00 PM ET on December 31, 2025. The government retains discretion to conduct a competitive procurement based on responses received, and submitted information will be evaluated primarily to determine whether competitive solicitation is warranted.

This procurement carries no set-aside designations and is anticipated to result in a firm fixed price maintenance contract with Bruker Scientific LLC for the period of January 17, 2026 through January 16, 2027. The contract classification falls under NAICS 811210 (Electronic and Precision Equipment Repair and Maintenance) and PSC J066 (Maintenance/Repair/Rebuild of Equipment – Instruments and Laboratory Equipment). No specific budget range or award value has been disclosed in this pre-solicitation notice. The one-year performance period reflects the scope of annual maintenance services required to support the MALDI Biotyper system's operational requirements and quality assurance obligations. Current vendor interest and capability statements should address the specialized technical qualifications necessary to maintain this specialized analytical instrumentation.